Tutorials
ROCO:6677 (Taiwan)  
Anxo Pharmaceutical Co Ltd logo

Anxo Pharmaceutical Co Ltd

NT$ 20.40 (+0.49%) Aug 5
P/E:
51.00
P/B:
1.34
Market Cap:
NT$ 982.55M ($ 32.80M)
Enterprise V:
NT$ 1.57B ($ 52.46M)
Volume:
3.00
Avg Vol (2M):
6.08K
Volume:
3.00
Market Cap NT$:
982.55M
Market Cap $:
32.80M
PE Ratio:
51.00
Avg Vol (2-Month):
6.08K
Enterprise Value NT$:
1.57B
Enterprise Value $:
52.46M
PB Ratio:
1.34
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Anxo Pharmaceutical Co Ltd
8th Floor-3, Nanjing East Road, No. 206, Section 2, Taipei City, TWN
Description
Anxo Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in developing drugs which include prescription medication and consumer healthcare medication. The products of the company include cardiovascular system medication, central nervous system medication, diabetes medication, infectious medicine, and dermatology medication.
Name Current Vs Industry Vs History
Cash-To-Debt 0.28
Equity-to-Asset 0.38
Debt-to-Equity 1.12
Debt-to-EBITDA 7.35
Interest Coverage 3.12
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.21
Distress
Grey
Safe
Beneish M-Score -2.38
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 57.15
9-Day RSI 56.13
14-Day RSI 54.94
6-1 Month Momentum % -20.08
12-1 Month Momentum % -18.43

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.49
Quick Ratio 0.98
Cash Ratio 0.49
Days Inventory 187.3
Days Sales Outstanding 75.68
Days Payable 52.36

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.3

Financials

ROCO:6677's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil NT$) 824.1
EPS (TTM) (NT$) 0.4
Beta 0.15
Volatility % 15.36
14-Day RSI 54.94
14-Day ATR (NT$) 0.534126
20-Day SMA (NT$) 19.865
12-1 Month Momentum % -18.43
52-Week Range (NT$) 16.3 - 26.25
Shares Outstanding (Mil) 48.16

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Anxo Pharmaceutical Co Ltd Filings

Document Form Filing Date
No Filing Data